(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,2-dimethylhydrazine multiple interactions ISO RGD:732097 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC6A9 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:732097 6480464 Ethinyl Estradiol results in increased expression of SLC6A9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:732097 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:732096 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC6A9 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732097 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732097 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A9 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A9 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732097 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol increases expression ISO RGD:732097 6480464 n-butoxyethanol results in increased expression of SLC6A9 mRNA CTD PMID:19812364 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:732097 6480464 3 more ... CTD PMID:19467301 4,4'-sulfonyldiphenol increases methylation ISO RGD:732097 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SLC6A9 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:732097 6480464 Fenretinide results in increased expression of SLC6A9 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC6A9 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:732096 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC6A9 mRNA CTD PMID:20147733 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC6A9 mRNA CTD PMID:31881176 adefovir pivoxil decreases expression ISO RGD:732096 6480464 adefovir dipivoxil results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 aflatoxin B1 increases expression ISO RGD:732097 6480464 Aflatoxin B1 results in increased expression of SLC6A9 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:732096 6480464 Aflatoxin B1 results in increased methylation of SLC6A9 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:732096 6480464 aflatoxin B2 results in increased methylation of SLC6A9 intron CTD PMID:30157460 amphetamine affects response to substance ISO RGD:732097 6480464 SLC6A9 protein affects the susceptibility to Amphetamine CTD PMID:15159536 aristolochic acid A decreases expression ISO RGD:732096 6480464 aristolochic acid I results in decreased expression of SLC6A9 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:732096 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:732096 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:732096 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 benzamide multiple interactions EXP 6480464 benzamide analog binds to and results in decreased activity of SLC6A9 protein CTD PMID:18355687 benzo[a]pyrene increases expression ISO RGD:732097 6480464 Benzo(a)pyrene results in increased expression of SLC6A9 mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:732096 6480464 Benzo(a)pyrene affects the methylation of SLC6A9 intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:732096 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 benzo[a]pyrene decreases expression ISO RGD:732096 6480464 Benzo(a)pyrene results in decreased expression of SLC6A9 mRNA CTD PMID:22316170 bis(2-chloroethyl) sulfide decreases expression ISO RGD:732097 6480464 Mustard Gas results in decreased expression of SLC6A9 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate increases expression ISO RGD:732097 6480464 Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:732097 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:26982218 bisphenol A increases expression ISO RGD:732097 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:34585602 bisphenol A increases expression ISO RGD:732096 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A9 mRNA CTD PMID:25181051 butan-1-ol multiple interactions ISO RGD:732096 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC6A9 mRNA CTD PMID:33453195 cadmium dichloride decreases expression ISO RGD:732096 6480464 Cadmium Chloride results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 cannabidiol increases expression ISO RGD:732097 6480464 Cannabidiol results in increased expression of SLC6A9 mRNA CTD PMID:21542829 cannabidiol increases expression ISO RGD:732096 6480464 Cannabidiol results in increased expression of SLC6A9 mRNA CTD PMID:31518892 carbon nanotube decreases expression ISO RGD:732097 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:732097 6480464 Nanotubes more ... CTD PMID:25620056 casticin decreases expression ISO RGD:732097 6480464 casticin results in decreased expression of SLC6A9 mRNA CTD PMID:28444820 chlordecone increases expression ISO RGD:732097 6480464 Chlordecone results in increased expression of SLC6A9 mRNA CTD PMID:33711761 chloroacetaldehyde decreases expression ISO RGD:732096 6480464 chloroacetaldehyde results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:732097 6480464 Chlorpyrifos results in increased expression of SLC6A9 mRNA CTD PMID:34289071 choline multiple interactions ISO RGD:732097 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 cidofovir anhydrous decreases expression ISO RGD:732096 6480464 Cidofovir results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:732097 6480464 Ciguatoxins affects the expression of SLC6A9 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:732096 6480464 Cisplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 cisplatin multiple interactions ISO RGD:732096 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC6A9 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:732097 6480464 Clobetasol results in increased expression of SLC6A9 mRNA CTD PMID:27462272 clodronic acid decreases expression ISO RGD:732096 6480464 Clodronic Acid results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SLC6A9 mRNA CTD PMID:17602206 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC6A9 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 coumarin increases expression EXP 6480464 coumarin results in increased expression of SLC6A9 mRNA CTD PMID:18480146 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC6A9 mRNA CTD PMID:27523638 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC6A9 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:732096 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC6A9 mRNA CTD PMID:23640034 , PMID:23914054 dexamethasone decreases expression ISO RGD:732096 6480464 Dexamethasone results in decreased expression of SLC6A9 mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO RGD:732096 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 diazinon increases methylation ISO RGD:732096 6480464 Diazinon results in increased methylation of SLC6A9 gene CTD PMID:22964155 dibenzo[a,l]pyrene multiple interactions ISO RGD:732096 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC6A9 mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 diclofenac decreases expression ISO RGD:732097 6480464 Diclofenac results in decreased expression of SLC6A9 mRNA CTD PMID:35537566 dioxygen multiple interactions ISO RGD:732097 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC6A9 mRNA] CTD PMID:22629407 dioxygen decreases expression ISO RGD:732096 6480464 Oxygen deficiency results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 dioxygen increases expression ISO RGD:732097 6480464 Oxygen deficiency results in increased expression of SLC6A9 mRNA CTD PMID:22629407 disodium selenite increases expression ISO RGD:732096 6480464 Sodium Selenite results in increased expression of SLC6A9 mRNA CTD PMID:24383545 disulfiram multiple interactions ISO RGD:732096 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC6A9 mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:732096 6480464 Doxorubicin results in decreased expression of SLC6A9 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:29391264 endosulfan increases expression ISO RGD:732096 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:30090376 epoxiconazole affects expression ISO RGD:732097 6480464 epoxiconazole affects the expression of SLC6A9 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:732097 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:732096 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 fenofibrate increases expression ISO RGD:732096 6480464 Fenofibrate results in increased expression of SLC6A9 mRNA CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SLC6A9 mRNA CTD PMID:23962444 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC6A9 mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732097 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC6A9 mRNA CTD PMID:33387578 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of SLC6A9 mRNA CTD PMID:26391144 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of SLC6A9 gene CTD PMID:31011160 ibuprofen increases expression ISO RGD:732096 6480464 Ibuprofen results in increased expression of SLC6A9 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:732096 6480464 Ifosfamide results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 L-methionine multiple interactions ISO RGD:732097 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC6A9 mRNA CTD PMID:11578147 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC6A9 mRNA CTD PMID:16507785 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC6A9 mRNA CTD PMID:25596134 , PMID:31324951 methamphetamine increases response to substance ISO RGD:732096 6480464 SLC6A9 gene SNP results in increased susceptibility to Methamphetamine CTD PMID:17582620 methotrexate affects expression ISO RGD:732097 6480464 Methotrexate affects the expression of SLC6A9 mRNA CTD PMID:18502557 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:732097 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:732097 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:732097 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:22776087 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SLC6A9 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 nobiletin increases expression EXP 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 nobiletin increases expression ISO RGD:732096 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC6A9 mRNA CTD PMID:23439660 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:732097 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC6A9 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC6A9 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:732097 6480464 Acetaminophen affects the expression of SLC6A9 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:732096 6480464 Acetaminophen results in increased expression of SLC6A9 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:732096 6480464 Acetaminophen results in decreased expression of SLC6A9 mRNA CTD PMID:26690555 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC6A9 mRNA CTD PMID:17077588 , PMID:18198484 pentachlorophenol increases expression ISO RGD:732097 6480464 Pentachlorophenol results in increased expression of SLC6A9 mRNA CTD PMID:23892564 perfluorononanoic acid increases expression ISO RGD:732096 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC6A9 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732097 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of SLC6A9 mRNA CTD PMID:33483757 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 phenobarbital multiple interactions ISO RGD:732097 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC6A9 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:732097 6480464 Phenobarbital affects the expression of SLC6A9 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:732097 6480464 Phenobarbital results in increased expression of SLC6A9 mRNA CTD PMID:19482888 phorone affects expression EXP 6480464 phorone affects the expression of SLC6A9 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:732097 6480464 pirinixic acid results in increased expression of SLC6A9 mRNA CTD PMID:18301758 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A9 mRNA CTD PMID:19162173 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC6A9 mRNA CTD PMID:22431067 rifampicin increases expression ISO RGD:732096 6480464 Rifampin results in increased expression of SLC6A9 mRNA CTD PMID:27199754 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC6A9 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:732096 6480464 Rotenone results in decreased expression of SLC6A9 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:732096 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of SLC6A9 mRNA CTD PMID:33725128 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of SLC6A9 mRNA CTD PMID:15967596 silicon dioxide increases expression ISO RGD:732096 6480464 Silicon Dioxide analog results in increased expression of SLC6A9 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:732096 6480464 Silicon Dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:25351596 sodium arsenite decreases expression ISO RGD:732097 6480464 sodium arsenite results in decreased expression of SLC6A9 mRNA CTD PMID:31170414 sodium arsenite decreases expression ISO RGD:732096 6480464 sodium arsenite results in decreased expression of SLC6A9 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:732096 6480464 sodium arsenite results in increased expression of SLC6A9 mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:732097 6480464 Sodium Fluoride results in increased expression of SLC6A9 mRNA CTD PMID:27862939 sotorasib multiple interactions ISO RGD:732096 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC6A9 mRNA CTD PMID:36139627 sunitinib increases expression ISO RGD:732096 6480464 Sunitinib results in increased expression of SLC6A9 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:732097 6480464 Tamoxifen results in decreased expression of SLC6A9 mRNA CTD PMID:25123088 tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of SLC6A9 mRNA CTD PMID:15885361 tetrachloroethene increases expression ISO RGD:732097 6480464 Tetrachloroethylene results in increased expression of SLC6A9 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC6A9 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:732096 6480464 Thapsigargin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 titanium dioxide decreases expression ISO RGD:732097 6480464 titanium dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:29264374 titanium dioxide increases expression ISO RGD:732096 6480464 titanium dioxide results in increased expression of SLC6A9 mRNA CTD PMID:34973136 toluene affects expression EXP 6480464 Toluene affects the expression of SLC6A9 mRNA CTD PMID:18653662 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:732096 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC6A9 mRNA CTD PMID:36139627 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC6A9 mRNA CTD PMID:33387578 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SLC6A9 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:732097 6480464 triptonide results in decreased expression of SLC6A9 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732096 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC6A9 mRNA CTD PMID:29024780 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 trovafloxacin decreases expression ISO RGD:732097 6480464 trovafloxacin results in decreased expression of SLC6A9 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:732096 6480464 Tunicamycin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 , PMID:29453283 urethane decreases expression ISO RGD:732096 6480464 Urethane results in decreased expression of SLC6A9 mRNA CTD PMID:28818685 vanadium atom decreases expression ISO RGD:732096 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:732096 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753
